Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-5-27
pubmed:abstractText
The L-phenylalanine oxidase IL4I1 inhibits T-cell proliferation in vitro through H(2) O(2) production, and is highly expressed in tumor-associated macrophages. IL4I1 is also detected by immunohistochemistry in neoplastic cells from several B-cell lymphomas and some non-lymphoid tumors. To evaluate IL4I1's effect on tumor growth, we developed a mouse melanoma model constitutively coexpressing IL4I1 and the GP33 epitope. After GP33 vaccination, tumors developed more frequently in mice injected with IL4I1-expressing cells in comparison with mice receiving control cells. Tumor escape was preceded by a rapid diminution of IFN-?-producing cytotoxic antitumor CD8(+) T cells. Moreover, tumor incidence was already increased when only 20% of the injected cells expressed IL4I1. The minimal IL4I1 activities leading to tumor escape were close to those detected in human melanoma and mesothelioma. Thus, we demonstrate the immunosuppressive functions of IL4I1 in vivo and suggest that IL4I1 facilitates human tumor growth by inhibiting the CD8(+) antitumor T-cell response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1521-4141
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
pubmed:issnType
Electronic
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1629-38
pubmed:meshHeading
pubmed-meshheading:21469114-Amino Acid Oxidoreductases, pubmed-meshheading:21469114-Animals, pubmed-meshheading:21469114-Antigens, Neoplasm, pubmed-meshheading:21469114-Antigens, Viral, pubmed-meshheading:21469114-CD8-Positive T-Lymphocytes, pubmed-meshheading:21469114-Cell Growth Processes, pubmed-meshheading:21469114-Glycoproteins, pubmed-meshheading:21469114-Humans, pubmed-meshheading:21469114-Hydrogen Peroxide, pubmed-meshheading:21469114-Immunization, pubmed-meshheading:21469114-Immunosuppression, pubmed-meshheading:21469114-Interferon-gamma, pubmed-meshheading:21469114-Lymphocyte Activation, pubmed-meshheading:21469114-Melanoma, Experimental, pubmed-meshheading:21469114-Mice, pubmed-meshheading:21469114-Mice, Transgenic, pubmed-meshheading:21469114-Neoplasms, Experimental, pubmed-meshheading:21469114-Peptide Fragments, pubmed-meshheading:21469114-Transgenes, pubmed-meshheading:21469114-Tumor Escape, pubmed-meshheading:21469114-Viral Proteins
pubmed:year
2011
pubmed:articleTitle
IL4I1: an inhibitor of the CD8? antitumor T-cell response in vivo.
pubmed:affiliation
INSERM, U955, Créteil, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't